Concepedia
Statistics
Publications
59
Citations
3.5K
H-Index
28
Active since
1987
Affiliations
University of Colorado Boulder(Current)
The University of Texas MD Anderson Cancer Center
Guangzhou Medical University
St. John's University
Vanderbilt University
Tong Shen is an author at University of Colorado Boulder specializing in medicine, pharmacology, and natural sciences.
Publications per year
1987–2024
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 769 citations · Full text
Medicine, Hematology, Oncology +9
Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance
Zhi Shi, Xing-Xiang Peng, In‐Wha Kim et al. · Cancer Research · 2007 · 329 citations
Medicine, Oncology, Pharmacology +16
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 273 citations
Medicine, Pharmacology, Pharmacotherapy +17
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole et al. · Blood · 2021 · 200 citations · Full text
Medicine, Hematology, Oncology +16
Human Multidrug Resistance Protein 7 ( <i>ABCC10</i> ) Is a Resistance Factor for Nucleoside Analogues and Epothilone B
Elizabeth Hopper-Borge, Xiu Xu, Tong Shen et al. · Cancer Research · 2008 · 154 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 59